Alejandro Rodriguez, MD
Urology · Winston Salem, NCNPI 1740489376
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,256 of the $17,051 with a category attached, or 77.7%. Recordati_rare_diseases_inc. accounts for 77.7% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $13,702, more than ten times the $866 reported in 2019. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $293.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Recordati_rare_diseases_inc.$13K
- EDAP Technomed Inc$615
- Coloplast$543
- Boston Scientific$437
- Urogen Pharma, Inc.$321
- Procept Biorobotics Corporation$306
- plus $2K from 12 others
Across 8 payments — averaging $3186.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$25K
What the payments were for
- Consulting fees$13,25678%
- Grants$2501%
- Food & beverage$3,44620%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Recordati_rare_diseases_inc. | 2 | $13,256 |
| EDAP Technomed Inc | 4 | $615 |
| Coloplast | 12 | $543 |
| Boston Scientific | 9 | $437 |
| Urogen Pharma, Inc. | 4 | $321 |
| Procept Biorobotics Corporation | 3 | $306 |
| Cook Medical LLC | 1 | $250 |
| Pfizer | 4 | $244 |
| Astellas Pharma US Inc | 3 | $240 |
| Neotract Inc. | 3 | $217 |
| Dendreon Pharmaceuticals LLC | 4 | $182 |
| Intuitive Surgical | 2 | $175 |
| Koelis Inc. | 1 | $105 |
| Telix Pharmaceuticals | 1 | $67 |
| AbbVie | 2 | $29 |
| Antares Pharma, Inc. | 1 | $23 |
| AstraZeneca | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JELMYTO$286
- SpaceOAR VUE System - 10mL$235
- XTANDI$230
- AquaBeam Robotic System$193
- PROVENGE$138
- Da Vinci Surgical System$126
- rezum Generator$123
- UroLift$113
- TRINITY$105
How this compares
$17,051 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $7,903 |
| Tamsulosin Hcl | 97 | $759 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 36 | $536 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $411 |
| Ciprofloxacin Hcl | 52 | $291 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $184 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $127 |
| Finasteride | 11 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $240 | $7,90312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 434 urology providers in North Carolina.
Other urology in Winston Salem
- Ryan TerleckiWinston Salem$219K
- Soroush Rais-BahramiWinston Salem$66K
- Ethan MatzWinston Salem$62K
- Kyle ScarberryWinston Salem$57K
- Connor PolicastroWinston Salem$53K
- Colin KleinguetlWinston Salem$52K
- Anthony AtalaWinston Salem$26K
- Gopal BadlaniWinston Salem$25K
- John SmithWinston Salem$17K
- Robert LippittSmithfield$11.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.